fda drug shortages semaglutide injection status resolved 2025 The weight loss shortage is over — and some patients are 'panicking' fda shortage semaglutide injection resolved

Let the pen or drawn syringe sit at room temperature for 1530 minutes first

In PIONEER-4, nausea occurred in 20% of patients on oral semaglutide 14 mg versus 18% on liraglutide 1.8 mg [1]

The UK SmPC does not list a contraindication related to medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2

Originally developed for type 2 diabetes management, GLP-1 medications have also shown remarkable efficacy in supporting significant weight loss for many individuals

What Were Reading features excerpts from recent articles offering a range of perspectives on topics shaping our community and the wider world